Active Ingredient(s): Levoketoconazole
FDA Approved: * December 30, 2021

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Recorlev Overview

Levoketoconazole, sold under the brand name Recorlev, is a steroidogenesis inhibitor that used for the treatment of Cushing's syndrome.[2][3][4][5] Levoketoconazole was approved for medical use in the United States in December 2021.[6][7] Levoketoconazole is the levorotatory or (2S,4R) enantiomer of ketoconazole,[3][4][5] and it is an inhibitor of the...

Read more Recorlev Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Recorlev Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Tablet: 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Levoketoconazole or a similar ingredient: (1 result)